Development and validation of an HPLC method for the rapid and simultaneous determination of 6-mercaptopurine and four of its metabolites in plasma and red blood cells

This publication has 20 references indexed in Scilit:

• Review article: practical management of inflammatory bowel disease patients taking immunomodulators
  Alimentary Pharmacology & Therapeutics, 2005
• Review article: monitoring of immunomodulators in inflammatory bowel disease
  Alimentary Pharmacology & Therapeutics, 2005
• The Utility of 6-Thioguanine Metabolite Levels in Managing Patients with Inflammatory Bowel Disease
  American Journal of Gastroenterology, 2004
• Optimizing treatment with thioguanine derivatives in inflammatory bowel disease
  Best Practice & Research Clinical Gastroenterology, 2003
• 6-Mercaptopurine Metabolite Levels in Children With Inflammatory Bowel Disease
  Journal of Pediatric Gastroenterology and Nutrition, 2001
• Variable Correlation Between 6-Mercaptopurine Metabolites in Erythrocytes and Hematologic Toxicity: Implications for Drug Monitoring in Children With Acute Lymphoblastic Leukemia
  Therapeutic Drug Monitoring, 2000
• Genetic polymorphism of thiopurine methyltransferase and its clinical relevance for childhood acute lymphoblastic leukemia
  Leukemia, 2000
• Analysis of thiopurine methyltransferase variant alleles in childhood acute lymphoblastic leukaemia
  British Journal of Haematology, 1999
• Altered mercaptopurine metabolism, toxic effects, and dosage requirement in a thiopurine methyltransferase-deficient child with acute lymphocytic leukemia
  The Journal of Pediatrics, 1991
• Assay of 6-thioinosinic acid and 6-thioguanine nucleotides, active metabolites of 6-mercaptopurine, in human red blood cells
  Journal of Chromatography B: Biomedical Sciences and Applications, 1987